Genistein: A focus on several neurodegenerative diseases
- PMID: 35460092
- DOI: 10.1111/jfbc.14155
Genistein: A focus on several neurodegenerative diseases
Abstract
Neurodegenerative diseases are caused by the progressive loss of function or structure of nerve cells in the central nervous system. The most common neurodegenerative diseases include Alzheimer's disease, Huntington's disease, motor neuron disease, and Parkinson's disease. Although the physical or mental symptoms of neurodegenerative disease may be relieved by various treatment combinations, there are currently no strategies to directly slow or prevent neurodegeneration. Given the demographic evidence of a rapidly growing aging population and the associated prevalence of these common neurodegenerative diseases, it is paramount to develop safe and effective ways to protect against neurodegenerative diseases. Most neurodegenerative diseases share some common etiologies such as oxidative stress, neuroinflammation, and mitochondrial dysfunction. Genistein is an isoflavone found in soy products that have been shown to exhibit antioxidant, anti-inflammation, and estrogenic properties. Increasing evidence indicates the protective potential of genistein in neurodegenerative disorders. In this review, we aim to provide an overview of the role that genistein plays in delaying the development of neurodegenerative disease. PRACTICAL APPLICATIONS: Genistein is a naturally occurring isoflavone found mainly in soybean, but also green peas, legumes, and peanuts. Genistein is found to pass through the blood-brain barrier and possess a neuroprotective effect. In this review, we discuss studies in support of these actions and the underlying biological mechanisms. Together, these data indicate that genistein may hold neuroprotective effects in either delaying the onset or relieving the symptoms of neurodegenerative disease.
Keywords: Alzheimer's disease; Parkinson's disease; anti-inflammation; antioxidant; genistein; motor neuron disease.
© 2022 Wiley Periodicals LLC.
References
REFERENCES
-
- Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., & Fukami, Y. (1987). Genistein, a specific inhibitor of tyrosine-specific protein kinases. The Journal of Biological Chemistry, 262(12), 5592-5595.
-
- Alzheimer's, A. (2019). 2019 Alzheimer's disease facts and figures. Alzheimer's & Dementia, 15(3), 321-387. https://doi.org/10.1016/j.jalz.2019.01.010
-
- Andrade, J. E., Twaddle, N. C., Helferich, W. G., & Doerge, D. R. (2010). Absolute bioavailability of isoflavones from soy protein isolate-containing food in female BALB/c mice. Journal of Agricultural and Food Chemistry, 58(7), 4529-4536. https://doi.org/10.1021/jf9039843
-
- Arbabi, E., Hamidi, G., Talaei, S. A., & Salami, M. (2016). Estrogen agonist genistein differentially influences the cognitive and motor disorders in an ovariectomized animal model of parkinsonism. Iranian Journal of Basic Medical Sciences, 19(12), 1285-1290. https://doi.org/10.22038/ijbms.2016.7911
-
- Aronin, N., & DiFiglia, M. (2014). Huntingtin-lowering strategies in Huntington's disease: Antisense oligonucleotides, small RNAs, and gene editing. Movement Disorders: Official Journal of the Movement Disorder Society, 29(11), 1455-1461. https://doi.org/10.1002/mds.26020
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical